Evaluating guided bronchoscopy for diagnosing lung cancer
Official title: Korean Multicenter Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
Run by Seoul National University Bundang Hospital · NCT05804786 · Data updated 2026-11-12
This study is testing if a new guided bronchoscopy method is safe and effective for diagnosing lung cancer in patients with suspicious lung lesions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 1240 (estimated) |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Locations | 11 sites (Daegu and 10 other locations) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | May 10, 2024 |
| Trial ID | NCT05804786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 19 years old with peripheral lung lesions suspected of lung cancer who require a diagnostic biopsy.
✕Probably not a fit
Patients unable to provide informed consent or those with cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the safety and effectiveness of advanced guided bronchoscopy techniques for obtaining histological diagnoses of peripheral lung lesions suspected of being cancerous. Patients with such lesions will be recruited and undergo bronchoscopy procedures as part of their standard care, with the study focusing on analyzing the outcomes and characteristics of these procedures in a real-world setting. The study will track diagnostic yield, sensitivity, safety, and other factors over a follow-up period of up to one year.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy and safety of lung cancer diagnoses, leading to earlier and more effective treatment options for patients.
How similar studies have gone: Previous studies utilizing guided bronchoscopy techniques have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who agreed in writing to participate in this study 2. Adult men and women over 19 years of age 3. Patients who visited the hospital with lung lesions suspected of lung cancer and require a diagnostic biopsy 4. Patients capable of biopsy through guided bronchoscopy Exclusion Criteria: 1\) Patients who are unable to express their opinions and cannot cooperate due to a lack of cognitive function
Where it's running
-
Dongsan Hospital Keimyung University School of Medicine
Daegu, South Korea Recruiting -
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea Recruiting -
Chunnam National University Hwasun Hospital
Hwasun, South Korea Recruiting -
Inje University Ilsan Paik Hospital
Ilsan, South Korea Recruiting -
Gyeongsang National University Hospital
Jinju, South Korea Recruiting -
Seoul National University Bundang Hospital
Seongnam-si, South Korea Recruiting
Show 5 more locations
-
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea Recruiting -
Gangnam Severence Hospital
Seoul, South Korea Recruiting -
Hanyang University Hostpital
Seoul, South Korea Recruiting -
The Catholic University of Korea, Seoul, Korea
Seoul, South Korea Recruiting -
Pusan National University Yangsan Hospital
Yangsan, South Korea Recruiting
Study contacts
- Principal investigator: Yeon Wook Kim, MD., PhD — Seoul National University Bundang Hospital
- Study coordinator: Yeon Wook Kim, MD., PhD
- Email: kimyw@snu.ac.kr
- Phone: +82-31-787-8134
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.